What does Arbutus Biopharma Corporation do?
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a…
What is Arbutus Biopharma Corporation's P/E and P/B ratio?
Arbutus Biopharma Corporation has a P/E ratio of 5.3 and a P/B ratio of 2.49.
What is Arbutus Biopharma Corporation's debt-to-equity ratio?
Arbutus Biopharma Corporation has a debt-to-equity ratio of 0.01.
How much does Arbutus Biopharma Corporation owe compared with what it owns?
Arbutus Biopharma Corporation owes $0.06 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Arbutus Biopharma Corporation's Positivity rank?
Arbutus Biopharma Corporation is ranked #2,447 of 6,774 companies globally and #785 of 4,000 in United States on PositoAI, with a Positivity Score of 21,508.
Does Arbutus Biopharma Corporation have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Arbutus Biopharma Corporation.
Where can I read the latest news about Arbutus Biopharma Corporation?
Recent headlines about Arbutus Biopharma Corporation from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Arbutus Biopharma Corporation have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Arbutus Biopharma Corporation's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.